Is Insulin Glargine (IG) YFGN the same strength as Lantus (Insulin Glargine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 1, 2025 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Insulin Glargine YFGN and Lantus Have the Same Strength

Yes, insulin glargine YFGN has the same strength as Lantus, both containing insulin glargine at the same concentration (100 units/mL).

Understanding Insulin Glargine Products

Insulin glargine is a long-acting basal insulin analog that provides relatively constant, peakless glucose-lowering activity for approximately 24 hours. According to the American Diabetes Association (ADA) guidelines, insulin glargine products share the following characteristics:

  • All insulin glargine formulations (including Lantus and YFGN) contain the same active ingredient at the same concentration 1
  • They are designed to provide basal insulin coverage with a duration of action up to 24 hours 2
  • They are typically administered once daily to regulate hepatic glucose production and limit hyperglycemia overnight and between meals 3

Clinical Equivalence

The ADA recognizes insulin glargine formulations as therapeutically equivalent in their pharmacokinetic properties:

  • All insulin glargine products work by the same mechanism - precipitation in the neutral pH of subcutaneous tissue after injection, creating a depot that slowly releases insulin 4
  • They all provide a relatively constant basal insulin level without pronounced peaks 5, 6
  • The strength (100 units/mL) is standardized across insulin glargine products including Lantus and YFGN 2

Practical Implications

When switching between Lantus and insulin glargine YFGN:

  • No dose adjustment is needed when transitioning between these products
  • Both products can be administered once daily at the same dose
  • Both are equally effective at controlling fasting blood glucose levels 5
  • Both have similar safety profiles with comparable risks of hypoglycemia 4

Important Considerations

While the strength is identical, there are some practical points to remember:

  • Always check the insulin concentration on the label (100 units/mL for both products)
  • Never mix insulin glargine with other insulins in the same syringe as it may alter the time-action profile 7
  • Both products should be stored according to manufacturer recommendations
  • Insulin glargine products are not for intravenous use

Clinical Benefits of Insulin Glargine

Both Lantus and insulin glargine YFGN offer the same clinical advantages:

  • Lower risk of nocturnal hypoglycemia compared to NPH insulin 5, 4
  • Relatively constant basal insulin levels without pronounced peaks 6
  • Once-daily dosing for most patients, though some may benefit from twice-daily administration 7
  • Effective for both type 1 and type 2 diabetes management 5

In conclusion, patients can be reassured that insulin glargine YFGN and Lantus contain the same active ingredient at identical strength and can be used interchangeably without dose adjustment.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.